オメプラゾールに関連した現実の有害事象の理解を更新

Jijun Zhang^1,2, Jie An²

¹Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.

PloS one

|August 20, 2025

まとめ

腎臓や尿路に重大な問題があることがわかった. 実際のデータでは副作用以外にも危険性があることが示されていて慎重に使用することを勧めています

科学分野:

薬用警戒について
臨床安全性について
薬物使用

背景:

オメプラゾールは,酸性疾患に広く処方される陽子ポンプ阻害剤 (PPI) である.
過剰な使用と使用ガイドラインに関する認識の欠如は,安全性の再評価を必要とします.
記載されていない有害事象の可能性は調査が必要です.

研究の目的:

オメプラゾールの有害事象と安全性を評価する.
オメプラゾールの使用に伴う潜在的なリスクを特定する.
オメプラゾールのより安全な臨床適用のための証拠を提供するために.

主な方法:

FDA FAERSデータベース (Q1 2004 - Q4 2023) からの119, 159件のオメプラゾールの有害事象報告の分析.
指示,併用薬,および安全性信号を評価するための不均衡性分析.
新しい副作用と誤用パターンの特定

主要な成果:

GERD,消化不良,胃潰瘍,胃炎などの一般的な症状があります.
アスピリン,リシノプリル,フロセミド,アトルバスタチン,メトプロロールとの頻繁な併用.
腎臓と尿路の障害 (CKD,AKI,腎不全) と二次性副甲状腺症のようなリストされていない反応の強い陽性信号.

結論:

オメプラゾールに関連した新しい有害事象が明らかになりました.
腎臓と泌尿器系に重大なリスクがあることが明らかになった.
オメプラゾールの処方とモニタリングの必要性を裏付ける証拠があります.

さらに関連する動画

04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K

06:46

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

2.9K

関連する概念動画

01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

525

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...

525

01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

569

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...

569

01:19

Pharmacovigilance

989

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

989

01:30

Peptic Ulcer Disease I: Introduction

287

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...

287

01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

445

In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...

445

01:26

Peptic Ulcer Disease IV: Management

145

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

145

関連する実験動画